Targeted Evaluation, Action, & Monitoring of Traumatic Brain Injury

NCT ID: NCT02657135

Last Updated: 2018-07-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

95 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-03-24

Study Completion Date

2018-03-23

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

TEAM-TBI (Targeted Evaluation, Action, and Monitoring of Traumatic Brain Injury) is a research study that brings together TBI patients, advanced evaluation methods, and experts in a multi-faceted study to address the heterogeneity of TBI and to evaluate the effects self-help strategies might have on TBI outcomes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

TEAM-TBI (Targeted Evaluation, Action, and Monitoring of Traumatic Brain Injury) proposes a new approach to clinical trials in TBI that will:

* Evolve diagnostic technology \& treatment
* Improve self-help strategies
* Lower cost and speed for delivery of effective strategies

The TEAM-TBI program proposes an innovative new approach to TBI clinical trials to overcome the limitations of past efforts and achieve long-awaited breakthroughs for TBI survivors. The study will involve a comprehensive 3-4 day intake evaluation, followed by a variety of remotely performed tasks during a 1-6 month follow-up period.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Traumatic Brain Injury (TBI)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

History of Traumatic Brain Injury

All participants have a history of TBI. At study outcome participants are provided treatment recommendations that are the result of a consensus meeting of all physician investigators. Follow up care is not provided by this clinical trial.

Group Type EXPERIMENTAL

Cognitive/Neuropsychological Testing

Intervention Type BEHAVIORAL

These tests will be used to determine how the participant will continue with future procedures, and depending on results, may involve the participant returning to complete subsequent testing.

Vestibular/Ocular-Motor Testing

Intervention Type OTHER

These assessments will involve a series of tests and questionnaires that focus on physical symptoms of TBI and will include dizziness, balance, ocular-motor coordination, and reflexes.

Cervical (Neck) Evaluation

Intervention Type OTHER

These assessments will involve a series of tests and questionnaires that focus on physical symptoms of TBI including neck mobility and pain levels.

Sleep Evaluation

Intervention Type OTHER

These evaluations will focus on assessing insomnia (duration, frequency, daytime consequences), combat exposure, and the presence and severity of trauma history.

HDFT MRI

Intervention Type OTHER

This MRI aims at providing qualitative and quantitative assessments of the nature, location, and extent of white matter injury.

MR Spectroscopy (MRS)

Intervention Type OTHER

This is a noninvasive diagnostic test for measuring biochemical changes in the brain.

MEG (Magnetoencephalography)

Intervention Type OTHER

This is a non-invasive neurophysiological technique that measures the magnetic fields generated by neuronal activity of the brain.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cognitive/Neuropsychological Testing

These tests will be used to determine how the participant will continue with future procedures, and depending on results, may involve the participant returning to complete subsequent testing.

Intervention Type BEHAVIORAL

Vestibular/Ocular-Motor Testing

These assessments will involve a series of tests and questionnaires that focus on physical symptoms of TBI and will include dizziness, balance, ocular-motor coordination, and reflexes.

Intervention Type OTHER

Cervical (Neck) Evaluation

These assessments will involve a series of tests and questionnaires that focus on physical symptoms of TBI including neck mobility and pain levels.

Intervention Type OTHER

Sleep Evaluation

These evaluations will focus on assessing insomnia (duration, frequency, daytime consequences), combat exposure, and the presence and severity of trauma history.

Intervention Type OTHER

HDFT MRI

This MRI aims at providing qualitative and quantitative assessments of the nature, location, and extent of white matter injury.

Intervention Type OTHER

MR Spectroscopy (MRS)

This is a noninvasive diagnostic test for measuring biochemical changes in the brain.

Intervention Type OTHER

MEG (Magnetoencephalography)

This is a non-invasive neurophysiological technique that measures the magnetic fields generated by neuronal activity of the brain.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18-60 years of age
* Fluent in English
* Documented history of TBI or blast exposure since 2001

Exclusion Criteria

* Inability to have MRI
* Pregnancy
* History of TIA within last 6 months.
* Presently involved in open litigation
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

United States Department of Defense

FED

Sponsor Role collaborator

University of Pittsburgh

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

David Okonkwo, MD, Phd

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Pittsburgh Neurotrauma Clinical Trials Center

Pittsburgh, Pennsylvania, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

W81XWH-14-2-0002

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Interdisciplinary Interventions After mTBI
NCT06815692 NOT_YET_RECRUITING
TBI Evaluation and Management (TEaM)
NCT04576715 RECRUITING NA
Attention Intervention Management
NCT01779427 WITHDRAWN NA
Mild TBI Assessment & Rehabilitation
NCT02920788 ACTIVE_NOT_RECRUITING NA